Prosecution Insights
Last updated: November 04, 2026
Application No. 18/849,832

RADIATION-PROTECTION DEVICE FOR A SYRINGE

Non-Final OA §112
Filed
Sep 23, 2024
Priority
Mar 24, 2022 — FR FR2202620 +1 more
Examiner
REDDY, SUNITA
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Lemer Pax
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
12m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
516 granted / 765 resolved
-2.5% vs TC avg
Strong +61% interview lift
Without
With
+61.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
46 currently pending
Career history
807
Total Applications
across all art units

Statute-Specific Performance

§101
6.1%
-33.9% vs TC avg
§103
39.6%
-0.4% vs TC avg
§102
14.3%
-25.7% vs TC avg
§112
36.5%
-3.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 765 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The disclosure is objected to because of the following informalities: “…a shield made of a transparent radiation-protection material, added into said side housing and positioned in rest on said rebate structure …” in para.[0012] needs to be corrected. A suggested correction is -- a shield made of a transparent radiation-protection material, added into said side housing and positioned [[in]] at rest on said rebate structure --, or -- a shield made of a transparent radiation-protection material, added into said side housing and positioned within at rest on said rebate structure – or -- a shield made of a transparent radiation-protection material, added into said side housing and positioned [[in]] to rest on said rebate structure --. Appropriate correction is required. Claim Objections Following claims are objected to because of the following informalities: Claims 1-9 include reference characters which are enclosed within parentheses. The use of reference characters is considered as having no effect on the scope of the claims. Since the reference characters are not afforded patentable weight, the reference characters enclosed within parentheses should be deleted from the claims. Claim 1 lines 1-2 “A radiation-protection device … intended to be fitted onto a syringe used for injecting a radioactive product, said syringe …comprising” needs to be corrected to -- A radiation-protection device … [[intended]] configured to be fitted onto a syringe used for injecting a radioactive product, said syringe …[[comprising]] including -- to avoid intended use/functional limitation interpretation as detailed in MPEP 2111.04 which states inter alia that claim scope is not limited by claim language that suggests or makes optional but does not require steps to be performed, or by claim language that does not limit a claim to a particular structure (See MPEP 2111.04 ). Claim 1 lines 10-11 “a front opening … through which said front end … of said syringe body … is intended to emerge” needs to be corrected to -- a front opening … through which said front end …of said syringe body …is [[intended]] configured to emerge -- to avoid intended use/functional limitation interpretation as detailed in MPEP 2111.04 which states inter alia that claim scope is not limited by claim language that suggests or makes optional but does not require steps to be performed, or by claim language that does not limit a claim to a particular structure (See MPEP 2111.04 ). Each of claims 2, 3, 7 recite at least one “intended to” encompassing limitations which needs to be corrected to avoid intended use/functional limitation interpretation as detailed in MPEP 2111.04 which states inter alia that claim scope is not limited by claim language that suggests or makes optional but does not require steps to be performed, or by claim language that does not limit a claim to a particular structure (See MPEP 2111.04 ). As an example, amend claim 2 lines 5-6 “a bottom face … of said locking member … being intended to bear against said rebate bottom …of said shield rebate” to -- a bottom face … of said locking member … being [[intended]] configured to bear against said rebate bottom …of said shield rebate--. Similar amendments are suggested for other “intended to” encompassing limitations i.e. replace “intended to “ to –configured to--. Claim 1 lines 8-9 “said tubular radiation-protection structure … comprising” needs to be corrected to -- said tubular radiation-protection structure … [[comprising]] including—to avoid clarity issue as to which combination or permutation of limitations proceeding claim 1 line 8-9 “comprising:” apply to claim 1 lines 8-9 comprising limitation. Claim 1 lines 16-17 “a shield … made of a transparent radiation-protection material, added into said side housing … and positioned in rest on said rebate structure” needs to be corrected. A suggested correction is -- a shield … made of a transparent radiation-protection material, added into said side housing … and positioned [[in]] at rest on said rebate structure—or -- a shield … made of a transparent radiation-protection material, added into said side housing … and positioned within at rest on said rebate structure—or -- a shield … made of a transparent radiation-protection material, added into said side housing … and positioned [[in]] to rest on said rebate structure--. Each of claims 1, 4, 6, 9 recite at least one or more “adapted to” encompassing limitations which need to be corrected to avoid potential intended use/functional limitation interpretation as detailed in MPEP 2111.04 which states inter alia that claim scope is not limited by claim language that suggests or makes optional but does not require steps to be performed, or by claim language that does not limit a claim to a particular structure (See MPEP 2111.04 discussion especially regarding “Adapted to,” “Adapted for,” and Contingent Clauses). As an example, [c1] claim 4 “wherein said retractable locking member … consists of an elastic locking ring … adapted to surround said tubular radiation-protection structure … and said associated shield … of transparent radiation-protection material” needs to be corrected to --wherein said retractable locking member … consists of an elastic locking ring … [[adapted]] configured to surround said tubular radiation-protection structure … and said associated shield … of transparent radiation-protection material-- . Similarly a proposed amendment to: [c2] claim 1 is --an inner surface (111) delimiting a central housing (112) [[adapted]] configured to receive at least part of said syringe body (3),—an outer surface (113),—a front opening (114) through which said front end (5) of said syringe body (3) is intended to emerge,—a rear opening (115) [[adapted]] configured for inserting and extracting said syringe body (3), and for operating said syringe plunger (8),—a side opening (116) that opens into said central housing (112), said side opening (116) comprising a rebate structure (117) and forming a side housing (118), (ii) a shield (12) made of a transparent radiation-protection material, added into said side housing (118) and positioned in rest on said rebate structure (117), said radiation-protection device (1) also comprising locking means (14) to lock said shield (12) of transparent radiation-protection material in said side housing (118), wherein said locking means (14) comprise a tenon structure (14a) arranged at one end (121) of said shield (12) of transparent radiation-protection material, [[adapted]] configured to cooperate with a complementary mortise structure (14b) arranged in said side housing (118), and a retractable locking member (14c) [[adapted]] configured to cooperate with another end (122) of said shield (12) of transparent radiation-protection material--; [c3] claim 6 is -- said projecting flat structure (23) being [[adapted]] configured to serve as a bearing structure, to be stably put on a receiving plane--; [c4] claim 9 is -- at least a part of non-circular cross-section [[adapted]] configured to avoid or limit its rolling on a receiving surface--. Claim 1 lines 25-27 “said locking member…being able to be activated to lock said shield … of transparent radiation-protection material in position after introduction of said tenon structure … into said mortise structure” needs to be corrected -- said locking member…configured to be activated to lock said shield … of transparent radiation-protection material in position after introduction of said tenon structure … into said mortise structure—as “being able to” is an intended use limitation and as such only requires recited structure has the ability/capability to so perform but does not necessarily have to perform the recited use/function. Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1305 (Fed. Cir. 1999). Claim 8 “wherein the outer surface … of said tubular radiation-protection structure … includes a slot …for the integration, at least partial, of said retractable locking member … in the form of an elastic ring” needs to be corrected. A suggested correction is -- wherein the outer surface … of said tubular radiation-protection structure … includes a slot …for the integration, at least [[partial]] partially, of said retractable locking member …which is in the form of an elastic ring --. Claim 9 “wherein the outer structure … of the tubular radiation-protection structure … comprises at least a part of non-circular cross-section” needs to be corrected. A suggested correction is -- wherein the outer structure … of the tubular radiation-protection structure … comprises at least [[a]] in part of non-circular cross-section—or -- wherein the outer structure … of the tubular radiation-protection structure … comprises at least [[a]] partly of non-circular cross-section--. Claim 3 line 14 “the end” needs to be corrected to –the another end—to maintain consistent terminology with its antecedent in claim 1 line 24 “another end”. Appropriate correction is required. Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (B) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 1-9 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which applicant regards as the invention. Claim 2 in line 2 recites “said end” which renders this claim unclear. More specifically, it is unclear as to whether claim 2 line 2 “said end” is referencing “one end” in claim 1 line 21 and/or “another end” in claim 1 line 24. Claim 7 in line 2 recites “said end” which renders this claim unclear. More specifically, it is unclear as to whether claim 7 line 2 “said end” is referencing “one end” in claim 1 line 21 and/or “another end” in claim 1 line 24. Claim 1 in lines 24-25 recites “a retractable locking member … adapted to cooperate with another end … of said shield … of transparent radiation-protection material” which renders this claim unclear in light of the remaining claim limitations as recited. More specifically, it is unclear as to how or in what manner the retractable locking member cooperates with another end of said shield of transparent radiation-protection material to lock the shield in the absence of any shield rebate to form the device as recited. Additionally, in the absence of shield rebate and shield rebate structures it is unclear as to how the retractable locking member cooperates with another end of said shield to axially/longitudinally lock the shield, Dependent claims 3-6, 8-9 when analyzed as a whole are held to be patent ineligible under 35 U.S.C. 112(b) because the additional recited limitations fail to cure the 35 U.S.C. 112(b) issue in their respective base claims. Consequently, dependent claims 3-6, 8-9 are also rejected under 35 U.S.C. 112(b) based on their direct/indirect dependency on their respective base claims. Examiner suggests merging claim 2 into claim 1 to cure this issue. Claim 9 in line 4 recites “its” which renders this claim unclear. More specifically, it is unclear as which of the preceding structures in claim 9 or base claim 1 is being referenced by claim 9 line 4 “its”. Dependent claims 2-9 when analyzed as a whole are held to be patent ineligible under 35 U.S.C. 112(b) because the additional recited limitations fail to cure the 35 U.S.C. 112(b) issue in their respective base claims. Consequently, dependent claims 2-9 are also rejected under 35 U.S.C. 112(b) based on their direct/indirect dependency on their respective base claims. Claim Interpretation 35 U.S.C. 112(f) The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations such as in claim 1 in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Claims that invoke 35 U.S.C 112 (f) Generic Placeholder Specification Support in instant application specification as-filed dated 09/23/2024 claim 1 “locking means ” Figure 3 “14”, [0049-0050] Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Interpretation Claims terms where relevant are being interpreted in light of definitions enumerated in instant application specification as-filed at least [0001], [0042]. Please note that USPTO personnel are to give claims their broadest reasonable interpretation in light of the supporting disclosure. In re Morris, 127 F.3d 1048, 1054-55, 44 USPQ2d 1023, 1027-28 (Fed. Cir. 1997). Limitations appearing in the specification but not recited in the claim should not be read into the claim. E-Pass Techs., Inc. v. 3Com Corp., 343 F.3d 1364, 1369, 67 USPQ2d 1947, 1950 (Fed. Cir. 2003) (claims must be interpreted "in view of the specification" without importing limitations from the specification into the claims unnecessarily). In re Prater, 415 F.2d 1393, 1404-05, 162 USPQ 541, 550-551 (CCPA 1969). See also In re Zletz, 893 F.2d 319, 321-22, 13 USPQ2d 1320, 1322 (Fed. Cir. 1989) ("During patent examination the pending claims must be interpreted as broadly as their terms reasonably allow.... The reason is simply that during patent prosecution when claims can be amended, ambiguities should be recognized, scope and breadth of language explored, and clarification imposed.... An essential purpose of patent examination is to fashion claims that are precise, clear, correct, and unambiguous. Only in this way can uncertainties of claim scope be removed, as much as possible, during the administrative process."). Contingently Allowable Subject-Matter As per dependent claim 2 and 7, dependent claims 2 and 7 would be contingently allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims in addition to overcoming any other rejections/objections enumerated above. Additionally, as per dependent claim 2 and 7, dependent claim 2 and 7 is being objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims in addition to overcoming any other rejections/objections enumerated above. The following is a statement of reasons for the indication of allowable subject matter: As per dependent Claim 2 and dependent Claim 7, none of the prior art discloses a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 4200804 A to Farella et al. discloses container and dispenser for radioactive material that includes a syringe with a barrel and manually actuated plunger. The barrel is covered by a body of radiation shielding material. A slot in the body is covered by a removable radiation shield, e.g. of optically transparent material. However, Farella does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 4060073 A to Collica et al. discloses syringe shield having generally cylindrical body formed of radiation-shielding material that is proportioned such that its inner surface conforms generally to the outer surface of the inner shell. The body has an elongated slot therein which is aligned with the slot in the inner shell. An outer shell, formed of plastic material, conforms to the shape of the outer surface of the body and has an elongated slot aligned with the slots in the inner shell in the body. An elongated optically transparent radiation shielding member is proportioned to fit in the elongated slot in the body. In one embodiment of Collica’s device has inner shell that has a plurality of flexible plastic protrusions on the inner surface thereof. However, Collica does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 20130317277 A1 to Lemer discloses radiation protection devices of the "syringe shield" type, which are intended to be fitted onto the syringes used for injecting radioactive material(s) for the protection of the operators against the ionizing radiation. More specifically, Lemer discloses protection device to be fitted onto a syringe used for injecting radioactive material(s). The radiation protection device includes a tubular radiation protection housing that includes an outer tubular part, which constitutes at least a portion of the outer surface thereof, and which is made of an elastomeric material. The tubular portion also includes an annular constrictive portion including a resiliently deformable inner surface that is used to apply a compressive force around the cylindrical body of the inserted syringe. However, Lemer does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 20170348485 A1 to Le Maitre et al. discloses a device for sampling and/or injection of a radioactive solution in a vial, wherein the vial comprises an opening closed by a puncturable closure member. The device having a container adapted to receive said vial and a vial adaptor, said vial adaptor having a longitudinal axis (L1), provided at a first end with a hollow spike adapted to pierce said puncturable closure member when the vial adaptor is mounted on the vial, and at a second end with connection means adapted for its removable connection to a syringe, the container includes a container body adapted to receive said vial, the container body having an opening, and a vial adaptor support structure configured for being mounted onto the opening of the container body, and includes retention means configured for enabling releasable retention of said vial adaptor within said vial adaptor support structure, and wherein the vial adaptor support structure and the container body are made at least partially of a radioprotective material for providing protection against ionizing radiation. However, Le Maitre does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 20040015038 A1 to Lemer discloses syringe protecting device that includes a casing made of a material protecting against radiation, that covers the syringe cylindrical body, which casing is associated with a structure made of a material protecting against radiation, designed to form at least a partial protective shield on the rear end of the syringe, while allowing the syringe plunger to be operated, wherein the protective shield is globally shaped like a cylindrical sleeve provided with a base; the sleeve is mounted sliding on the protective casing by capping it through its rear end, and it comprises mechanism for being removably secured to the stem operating the syringe plunger. However, Lemer does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 4056096 A to Collica et al. discloses radiation shield including syringe having a plastic barrel, a tip on the front of the barrel, and a plunger slideable in the barrel and extending from the rear of the barrel for manual actuation with a cylindrical body of radiation-shielding material substantially covering the barrel of the syringe. A plastic shell of cylindrical shape substantially covers the radiation-shielding body and the shell has a slot which is in registration with the slot in the radiation-shielding body. An optically transparent radiation-shielding member, such as a rectangular leaded-glass member, is proportioned to generally conform in size to the slot in the body and is removably insertible therein. However, Collica does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 3973554 A to Tipton discloses Tipton discloses safety apparatus for use in administering radioactive serums by a syringe, without endangering the health and safety of the medical operators, consists of a sheath and a shield which can be retracted into the sheath to assay the radioactive serum in an assay well. The shield can be moved from the retracted position into an extended position when the serum is to be injected into the patient. To protect the operator, the shield can be constructed of tantalum or any like high density substance to attenuate the radiation, emanating from the radioactive serums contained in the syringe, from passing to the atmosphere. A lead glass window is provided so that the operator can determine the exact quantity of the radioactive serum which is contained in the syringe. However, Tipton does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Prior art US 4092546 A to Larrabee discloses a protective shielding assembly for use in the loading of a hypodermic syringe with radioactive material. The protective shielding device receives and securely holds, at one end, a vial which contains the material to be loaded and at its opposite end a hypodermic syringe with the needle of the syringe approximately centered with respect to the septum of the vial. Penetration of the septum of the vial is effected by moving the slidable members of the protective shielding assembly toward the vial which in turn moves the hypodermic syringe causing the needle of the hypodermic syringe to rupture the vial septum and enter the vial. However, Larrabee does not disclose or render obvious a radiation-protection device wherein said end of the shield of transparent radiation-protection material cooperating with said locking member includes a shield rebate for receiving said locking member, said shield rebate being delimited by a rebate bottom and a rebate edge, a bottom face of said locking member being intended to bear against said rebate bottom of said shield rebate, to axially lock said shield of radio-protective material, and a thickness of said locking member being intended to come between said rebate edge of said shield rebate and an end face opposite said side housing, to longitudinally lock said shield of radio-protective material including all of the respective limitations, features, combination and arrangement of features of their respective base claim and any respective intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure and/or the claims. Prior art US 20210268187 A1 to Gertsenchtein discloses syringe shield for housing and transporting a syringe containing radioactive drug similar to that disclosed. More specifically, a syringe shield that includes a barrel housing, which includes: a barrel housing with a radiation-shielding material, a first open end, and a second open end; and a removable cover which is slidably connectable to the barrel housing. The removable cover includes an end cap which covers the second open end when the removable cover is slidably connected to the barrel housing. The barrel housing also includes a plunger housing with a radiation-shielding material. A first end of the plunger housing is open and is connectable to the first open end of the barrel housing, and a second end of the plunger housing includes a top cap. Prior art US 20040077919 A1 to Drobnik et al. discloses apparatus and method for administering a dose in brachytherapy procedures comprising a handheld housing containing a dose of radioactive seeds adapted for use in a brachytherapy treatment and a display for observing information about the dose and viewing the dose or components of the dose similar to that disclosed. Prior art US 20060069347 A1 to Besing discloses safety syringe sealing system that includes a radiation shield similar to that disclosed. The safety syringe sealing system includes the combination of a safety syringe and a plug. The safety syringe includes a barrel, a needle, a plunger and a needle sheath. The needle sheath is movable between a retracted position where the needle is exposed, to an extended position where the needle is protected, the needle sheath defining an open end. There is a plug that is engageable with the open end of the needle sheath when the needle sheath is in the extended position. The sealing system can also include a pharmaceutical pig, having a base and cap, where the base and cap define a hollow center section that is capable of receiving the safety syringe. Therefore, the safety syringe, having a plugged needle sheath, may be sealed within the pharmaceutical pig to prevent leakage and inadvertent exposure. Prior art US 20080086092 A1 to Loe discloses a syringe shield for protecting a user from radiation emanating from a radioactive liquid disposed within an enclosed syringe similar to that disclosed. More specifically, a syringe shield includes a tungsten component housing or barrel fitted with a yieldable grip and a lead glass window for receiving the vial of a syringe containing the radioactive material. A barrel lock fits over the syringe vial and engages the syringe entry end of the barrel, such that resilient fingers provided on the barrel lock engage a barrel taper in the barrel and bend inwardly from an extended configuration to grip the syringe vial and maintain the syringe in position inside the barrel. The barrel lock can be friction-fitted or threaded in the receiving end of the barrel or it may be provided with a bayonet coupling pin which engages a companion bayonet slot in the barrel to close the barrel lock on the barrel such that the fingers tightly, yet removably, engage the syringe vial in a compression fit. Prior art US 4307713 A and US 4401108 A both to Galkin et al discloses radiation shields for use by radio-pharmacists while withdrawing aliquots of radioactive materials similar to that disclosed. Prior art US 5716317 A to Okano et al. discloses a sheath for a syringe barrel, includes a main body in which a radiation shielding device for holding a syringe filled with pharmaceutical liquid therein similar to that disclosed. More specifically, a sheath for a syringe barrel, includes a main body in which a radiation shielding device for holding a syringe filled with pharmaceutical liquid therein is fitted, a male luer provided at a front end of the main body and designed to set a disposable needle, and a transfixing needle extending backward from inside of the male luer to penetrate a rubber plug at an opening at a front end of a syringe held in the main body. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUNITA REDDY whose telephone number is (571)270-5151. The examiner can normally be reached on M-Thu 10-4 EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, CHARLES A MARMOR II can be reached on (571)272-4730. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000 Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at http://www.uspto.gov/interviewpractice. /SUNITA REDDY/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Sep 23, 2024
Application Filed
Oct 30, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779239
MAGNETIC STIMULATION METHOD AND MACHINE
5y 1m to grant Granted Nov 03, 2026
Patent 12778844
HEALTH-CARE DEVICE
5y 1m to grant Granted Nov 03, 2026
Patent 12779238
SPINTRONIC NANODEVICE FOR LOW-POWER, CELLULAR-LEVEL, MAGNETIC NEUROSTIMULATION
4y 1m to grant Granted Nov 03, 2026
Patent 12779166
DEVICES AND METHODS FOR ENHANCING INTRANASAL AIR AND ODORANT DELIVERY PATTERNS
3y 7m to grant Granted Nov 03, 2026
Patent 12773517
SYSTEMS AND METHODS OF REDUCING STRESS WITH MUSIC
4y 9m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+61.2%)
3y 1m (~12m remaining)
Median Time to Grant
Low
PTA Risk
Based on 765 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month